BALPHARMA.NSBALPHARMA.NSNSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P21
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-81.44%
20241337.09%
2023-106.65%
202227.21%
2021-5.71%
2020197.79%
20191664.03%
2018-108.47%
2017130.27%
2016-233.17%